Although elevated serum CHI3L1 levels have been linked to increased mortality in melanoma patients, the primary sources of CHI3L1 are immune cells, such as macrophages and neutrophils, rather than tumor cells themselves [73,74,75]. This evidence concerns the gene CHI3L1 and melanoma.